Page last updated: 2024-09-02

tadalafil and Blood Pressure, Low

tadalafil has been researched along with Blood Pressure, Low in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Denne, J; Emmick, JT; Hutter, AM; Jackson, G; Kloner, RA; Mitchell, MI	1
Kloner, RA	1
Prisant, LM	1
Jung, F; Leithäuser, B; Park, JW	1

Reviews

2 review(s) available for tadalafil and Blood Pressure, Low

Article	Year
Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation, 2004, Nov-09, Volume: 110, Issue:19 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents	2004
Phosphodiesterase-5 inhibitors and their hemodynamic effects. Current hypertension reports, 2006, Volume: 8, Issue:4 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antihypertensive Agents; Blood Pressure; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Hypotension; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vascular Resistance	2006

Article

Year

Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction.

Circulation, 2004, Nov-09, Volume: 110, Issue:19

Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Arteriosclerosis; Blood Pressure; Carbolines; Contraindications; Coronary Disease; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Interactions; Endothelium, Vascular; Erectile Dysfunction; Heart Rate; Humans; Hypotension; Imidazoles; Isosorbide Dinitrate; Male; Molecular Structure; Myocardial Infarction; Nitric Oxide Donors; Nitroglycerin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilation; Vasodilator Agents

2004

Phosphodiesterase-5 inhibitors and their hemodynamic effects.

Current hypertension reports, 2006, Volume: 8, Issue:4

Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Antihypertensive Agents; Blood Pressure; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Hypotension; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vascular Resistance

2006

Trials

2 trial(s) available for tadalafil and Blood Pressure, Low

Article	Year
Time course of the interaction between tadalafil and nitrates. Journal of the American College of Cardiology, 2003, Nov-19, Volume: 42, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Carbolines; Contraindications; Cross-Over Studies; Double-Blind Method; Drug Synergism; Erectile Dysfunction; Humans; Hypotension; Male; Middle Aged; Nitrates; Phosphodiesterase Inhibitors; Tadalafil; Time Factors	2003
Sublingual application of liquid nitrendipine does not result in critical hypotension in healthy volunteers under phosphodiesterase-5 inhibition. Clinical hemorheology and microcirculation, 2008, Volume: 39, Issue:1-4 Topics: Administration, Sublingual; Adult; Angina Pectoris; Blood Pressure; Carbolines; Cardiovascular Diseases; Dosage Forms; Drug Interactions; Erectile Dysfunction; Humans; Hypotension; Male; Nitrendipine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil	2008

Article

Year

Time course of the interaction between tadalafil and nitrates.

Journal of the American College of Cardiology, 2003, Nov-19, Volume: 42, Issue:10

Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Carbolines; Contraindications; Cross-Over Studies; Double-Blind Method; Drug Synergism; Erectile Dysfunction; Humans; Hypotension; Male; Middle Aged; Nitrates; Phosphodiesterase Inhibitors; Tadalafil; Time Factors

2003

Sublingual application of liquid nitrendipine does not result in critical hypotension in healthy volunteers under phosphodiesterase-5 inhibition.

Clinical hemorheology and microcirculation, 2008, Volume: 39, Issue:1-4

Topics: Administration, Sublingual; Adult; Angina Pectoris; Blood Pressure; Carbolines; Cardiovascular Diseases; Dosage Forms; Drug Interactions; Erectile Dysfunction; Humans; Hypotension; Male; Nitrendipine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Tadalafil

2008